CrushSCI.com
Journal Selection & Manuscript Polishing Services
EXPERT OPINION ON PHARMACOTHERAPY journal cover Medicine
Back to journal directory

Review Cycle Records

EXPERT OPINION ON PHARMACOTHERAPY

Taylor & Francis SCIE Non-OA
2026 Emerging Zone 32025 CAS Zone 42025 JCR Q2
56.3Average days
50.5Median days
3Fastest days
119Longest days
1702025 publications

Paper Review Records

All Paper Review Records

10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

83 days

Recent advances in EGFR-targeted therapies for non-small cell lung cancer

AuthorsLuca Lucente; Lucrezia Barcellini; Beatrice Ramella Pollone; Clara Lidia Filipazzi; Simona Coco; Margherita Puppo; Silvia Marconi; Sara Santamaria; Marco Tagliamento; Giovanni Rossi; Chiara Dellepiane; Elisa Bennicelli; Giulia Barletta; Linda Zinoli; Carlo Genova

Affiliations1. AOM - IRCCS Ospedale Policlinico San Martino; 2. University of Genoa

Source PDF DOI Publisher page
85 days

Evaluating mitapivat for the treatment of alpha or beta thalassemia

AuthorsAntonis Kattamis; Konstantinos Bistas; Vangelis Mitros; Efthalia Faidra Agiomavriti Stefanopoulou; Polyxeni Delaporta

Affiliations1. National and Kapodistrian University of Athens; 2. ERN-EuroBloodNet Center

Source PDF DOI Publisher page
40 days

Gepotidacin in oral antibacterial pharmacotherapy: efficacy, safety, and clinical positioning

AuthorsMuhammad Saeed Akhtar

Affiliations1. Yeungnam University

Source PDF DOI Publisher page
40 days

Low-dose colchicine for atherosclerotic cardiovascular disease and the return of inflammation-targeted pharmacotherapy

AuthorsSajid Ali; Muhammad Siraj

Affiliations1. Yeungnam University; 2. Okayama University

Source PDF DOI Publisher page
3 days

Beyond the primary endpoint: what VICTOR really tells us about vericiguat

AuthorsBianca Larroux; Flavio Tangianu; Aldo Bonaventura

Affiliations1. University of Insubria; 2. Ospedale di Circolo and Fondazione Macchi, ASST Sette Laghi

Source PDF DOI Publisher page
28 days

Selecting optimal therapy in the evolving therapeutic landscape of metastatic pheochromocytoma and paraganglioma

AuthorsMoza Hamoud; Victor M. Samperio; Aishwarya Ghonge; Alainya Tomanec; Constantin A. Dasanu

Affiliations1. Eisenhower Health; 2. CHRISTUS Health; 3. Texas A&M University College of Medicine

Source PDF DOI Publisher page
61 days

Evaluation of delgocitinib for the treatment of moderate to severe chronic hand eczema in adults

AuthorsNicole Piaskowski; Philipp Globig; Margitta Worm

Affiliations1. Charité-Universitätsmedizin

Source PDF DOI Publisher page
64 days

The rise and fall of TRPV1-targeted analgesia in osteoarthritis: a critical appraisal

AuthorsCsaba Matta; Roland Takács; Eun-Jung Jin; Zsuzsanna Helyes; Ádám István Horváth; Krisztián Zoltán Juhász; Balázs István Tóth; Ron Ellis; Ali Mobasheri

Affiliations1. University of Debrecen; 2. Wonkwang University; 3. Organelle Therapeutic Inc; 4. University of Pécs; 5. National Laboratory for Drug Research and Development; 6. Hungarian Research Network-University Pécs (HUN-REN-PTE) Chronic Pain Research Group; 7. PharmInVivo Ltd; 8. Independent Researcher; 9. University of Oulu; 10. State Research Institute Centre for Innovative Medicine; 11. First Affiliated Hospital of Sun Yat-Sen University; 12. University of Liège; 13. University for Continuing Education Krems; 14. Maastricht University Medical Center

Source PDF DOI Publisher page
119 days

Current perspectives on β 2 -adrenergic receptor agonists in asthma: navigating from track to track within GINA recommendations

AuthorsLuigino Calzetta; Paola Rogliani

Affiliations1. University of Rome “Tor Vergata”

Source PDF DOI Publisher page
40 days

Pharmacological treatment of anhedonic depression: the role of dopaminergic and anti-inflammatory mechanisms

AuthorsDaniel Lindqvist

Affiliations1. Lund University; 2. Skåne University Hospital

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.